Bengaluru: FutureCure Health Private Limited is expanding its specialised vertigo care network in Bengaluru through its wholly owned subsidiary, NeuroEquilibrium. The move addresses a significant healthcare gap, as nearly six crore Indians suffer from vertigo and balance disorders, many of whom are misdiagnosed or treated only for symptoms.
NeuroEquilibrium focuses on identifying the precise root cause of vertigo—whether linked to the inner ear, brain, or balance system—enabling targeted and lasting treatment. The organisation works closely with hospitals, ENT clinics, and neurology centres, and has diagnosed and treated over 150,000 patients to date.
Dr. Anita Bhandari, Founder, FutureCure Health, said, “Vertigo and dizziness are often misdiagnosed, leaving patients untreated for years. Our experience with more than 150,000 patients shows that accurate diagnosis significantly improves outcomes. We aim to expand specialised vertigo care both nationally and globally.”
NeuroEquilibrium currently operates 16 clinics across Bengaluru, including Hebbal, Whitefield, HSR Layout, JP Nagar, Electronic City, and Malleswaram, among other locations.
The expansion follows a ₹104 crore funding round led by Carnelian Asset Management LLP, after an earlier USD 4 million raise backed by Kotak Alternate Asset Management, RVCF Ventures, and Unicorn India Ventures.
Rajneesh Bhandari, Founder, FutureCure Health, added that technology-driven diagnostics will help scale super-speciality care and bridge specialist shortages while expanding into chronic lifestyle diseases such as migraine and diabetes.
